Back to Search Start Over

Death after misuse of anabolic substances (clenbuterol, stanozolol and metandienone).

Authors :
Lehmann S
Thomas A
Schiwy-Bochat KH
Geyer H
Thevis M
Glenewinkel F
Rothschild MA
Andresen-Streichert H
Juebner M
Source :
Forensic science international [Forensic Sci Int] 2019 Oct; Vol. 303, pp. 109925. Date of Electronic Publication: 2019 Aug 08.
Publication Year :
2019

Abstract

A 34-year old male was found breathless and panting at home by his girlfriend three hours after a gym workout. Minutes later, he collapsed and died. Autopsy, histological and chemical analyses were conducted. The examination of the heart showed left ventricular hypertrophy, while the right coronary artery showed only a small vascular lumen (3 mm in diameter), due to its anatomical structure. In femoral blood concentrations of approx. 1 μg/L clenbuterol, approx. 56 μg/L stanozolol and approx. 8 μg/L metandienone, with trenbolone (<limit of quantification (LOQ)) were detected. Additionally, there were positive results in urine for boldenone, clomiphene, trenbolone, metandienone, stanozolol, clenbuterol and drostanolone, along with indications of testosterone and/or testosterone prohormones having been taken. In consideration of all aspects of this case, in can be assumed that the long-term consumption of anabolic androgen steroids (AAS) caused apparently pathological changes of the heart. Over and above, the combination of anatomical (small lumed coronary artery, ventricular hypertrophy) and substance-induced risk factors led to the fatal cardiovascular failure.<br /> (Copyright © 2019 Elsevier B.V. All rights reserved.)

Details

Language :
English
ISSN :
1872-6283
Volume :
303
Database :
MEDLINE
Journal :
Forensic science international
Publication Type :
Academic Journal
Accession number :
31499423
Full Text :
https://doi.org/10.1016/j.forsciint.2019.109925